Literature DB >> 20018219

Differential expression of new splice variants of the neurotensin receptor 1 gene in human prostate cancer cell lines.

Teresa A Almeida1, Yurena Rodriguez, Mariano Hernández, Ricardo Reyes, Aixa R Bello.   

Abstract

Neurotensin is a neuroendocrine peptide acting as a trophic factor in a variety of cells in vivo but it can also function as an autocrine growth factor in human prostate cancer cells in vitro. In addition, the high-affinity G protein-coupled NT receptor (NTS1) is overexpressed in prostate cancer cell lines. Increasing evidence argues for a direct correlation between specific alternative splice variants and cancer. We detected four splice variants of the NTS1 receptor in human prostate cancer cell lines. These isoforms include one or more exons skipping as well as an alternative 5' splice donor site and are expressed in the late-stage androgen independent prostate cancer cell lines PC3 and DU145, but not in the early-stage androgen-sensitive LNCaP or in normal prostate tissue, which only express the normal transcript. This result shows new splice variants of NTS1 for the first time. The differential expression observed among prostate cancer cell lines and normal prostate tissue opens the interesting possibility of a new role of NT/NTS1 pathway in prostate cancer. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018219     DOI: 10.1016/j.peptides.2009.12.007

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  2 in total

1.  Prostate cancer targeting motifs: expression of αν β3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts.

Authors:  Robert M Taylor; Virginia Severns; David C Brown; Marco Bisoffi; Laurel O Sillerud
Journal:  Prostate       Date:  2011-07-11       Impact factor: 4.104

2.  Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.

Authors:  Kristin M Müller; Ingun H Tveteraas; Monica Aasrum; John Ødegård; Mona Dawood; Olav Dajani; Thoralf Christoffersen; Dagny L Sandnes
Journal:  BMC Cancer       Date:  2011-10-02       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.